Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata

Clinical and Experimental Dermatology

Volumn 32, Issue 1, 2007, Pages 48-51

  Sotiriadis, D ^a   Patsatsi, A ^a   Lazaridou, E ^a,b   Kastanis, A ^a   Vakirlis, E ^a   Chrysomallis, F ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; DIPHENCYPRONE;

ADULT; ALOPECIA AREATA; ARTICLE; ATOPY; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECZEMA; FAMILY HISTORY; FEMALE; FOLLOW UP; HAIR GROWTH; HUMAN; IMMUNOTHERAPY; LYMPH NODE HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; PIGMENT DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALOPECIA AREATA; CHILD; CYCLOPROPANES; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33845803238     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02256.x     Document Type: Article

References (10)

1. Buckley DA, Du Vivier AW. The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol 2001; 145: 385-405.
2. Ujiie H, Sawamura D, Shibaki A, Shimizu H. Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata. Clin Exp Dermatol 2005; 30: 579-80.
3. Contellesa C, Peris K, Caracciolo E et al. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 2001; 44: 73-6.
4. Freyshchmidt-Paul P, Hoffmann R, Levine E et al. Current and potential agents for the treatment of alopecia areata. Curr Pharm Des 2001; 7: 213-30.
5. Tobin DJ, Gardner SH, Lindsey NJ et al. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata. Eur J Dermatol 2002; 12: 327-34.
6. Zoller M, McElwee KJ, Vitacolonna M, Hoffmann R. The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Exp Dermatol 2004; 13: 435-44.
7. Van der Steen PH, van Baar HM, Perret CM, Happle R. Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1992; 26: 276-7.
8. Alam M, Gross EA, Savin RC Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata. J Am Acad Dermato 1999; 40: 110-12.
9. Skrebova N, Nameda Y, Takiwaki H, Arase S. Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis. Contact Dermatitis 2000,; 42: 212-15.
10. Gordon PM, Aldridge RD, McVittie E, Hunter JAA. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months follow up. Br J Dermatol 1996; 134: 869-71.